Elizabeth A Brown1, Stephen P Hoffmann
1Division of Pulmonary and Critical Care Medicine, Ohio State University, Columbus, Ohio, USA. Brown-13@medctr.osu.edu
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Chronic inflammation causes end-stage lung disease, with limited treatment options. Lung transplantation, despite risks like infection and rejection, may improve survival and quality of life for patients with severe pulmonary conditions.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: